This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
As a class-action lawsuit gets rolling in California over the use of ambient AI in healthcare, a national law firm is drawing takeaways for hospitals and other provider organizations. Makes sense: All AI-equipped providers are potential targets for similar litigation now.
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized.
In hospitals serving mentally unstable patients, it’s no easy job to balance sensitive patient treatment with effective worker safety. One U.S. institution has been finding out just how hard it can be.
Manufacturer ICU Medical is aware of the issue, which stems from a report from an unnamed healthcare organization. The company and the FDA are asking providers to monitor IV lines for any signs of particulates.
While TAVR is safe for minimally symptomatic patients, questions remain about whether or not it is actually needed. A new analysis in JACC: Cardiovascular Interventions examines this topic in detail.
The new-look syringes are causing significant issues when used with syringe infusion pumps. This is a Class I recall, which means the FDA believes the products “may cause serious injuries or death.”
Less than a week after the famous Kowalski family won a $261 million civil judgment against a Johns Hopkins facility in Florida, Maya Kowalski is announcing she will slap the hospital with a criminal complaint alleging sexual assault.